Funding Details
- Awarder
- SemiNews
- Date Award
- April 07, 2025
- Vertical
- Neurotechnology
- Funding URL
- View Funding Page
Company Info
- Traction
- INBRAIN recently achieved a major milestone with the world’s first human application of its graphene-based BCI in an ongoing clinical trial at Salford Royal Hospital in Manchester, UK.
- Organizations Involved
- Merck KGaA, Salford Royal Hospital
- Founders
- Carolina Aguilar
- Company Description
- INBRAIN Neuroelectronics is a BCI therapeutics company using graphene to build the least invasive and most intelligent neural platform
- Market
- Healthcare
- Location
-
Barcelona,
Spain
- Coinvestors
- imec.xpand, EIC Fund, Fond ICO Next Tech, CDTI-Innvierte, Avançsa, Asabys Partners, Aliath Bioventures, Vsquared
Links